SBT-200

N/A

Report date: 2022/03/30 14:46:13

Base Information

Drug NameSBT-200

Drug Alias NameSBT-200

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitorsSignal transducer and activator of transcription 3 inhibitors

TargetsGTPase KRasSignal transducer and activator of transcription 3

Therapy Area/IndicationsEye Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSingh Biotechnology Llc

China Registration ClassN/A

Develop Information

Active CompaniesSingh Biotechnology Llc

Inactive CompaniesN/A

Active IndicationsEye Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A